BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 26614894)

  • 1. Historical overview of hairy cell leukemia.
    Andritsos LA; Grever MR
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia: Past, present and future.
    Getta BM; Park JH; Tallman MS
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):269-72. PubMed ID: 26614906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia.
    Dearden C
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
    [No Abstract]   [Full Text] [Related]  

  • 5. Hairy cell leukemia: update and current therapeutic approach.
    Salam L; Abdel-Wahab O
    Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoimmunotherapy for hairy cell leukemia.
    Ravandi F
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in the management of patients with hairy cell leukemia.
    Cornet E; Damaj G; Troussard X
    Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF inhibitor therapy in HCL.
    Dietrich S; Zenz T
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and diagnosis of hairy cell leukemia.
    Quest GR; Johnston JB
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoconjugates in the management of hairy cell leukemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF inhibition in refractory hairy-cell leukemia.
    Dietrich S; Glimm H; Andrulis M; von Kalle C; Ho AD; Zenz T
    N Engl J Med; 2012 May; 366(21):2038-40. PubMed ID: 22621641
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A Review.
    Sarvaria A; Topp Z; Saven A
    JAMA Oncol; 2016 Jan; 2(1):123-9. PubMed ID: 26513168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hairy cell leukemia: a 'hair-raising' update.
    Topp ZZ; Saven A
    Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
    Paillassa J; Maitre E; Troussard X
    Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
    Dietrich S; Hüllein J; Hundemer M; Lehners N; Jethwa A; Capper D; Acker T; Garvalov BK; Andrulis M; Blume C; Schulte C; Mandel T; Meissner J; Fröhling S; von Kalle C; Glimm H; Ho AD; Zenz T
    J Clin Oncol; 2013 Jul; 31(19):e300-3. PubMed ID: 23690412
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib.
    Vergote V; Dierickx D; Janssens A; Verhoef G; Tousseyn T; Vandenberghe P; Wolter P; Delforge M
    Ann Hematol; 2014 Dec; 93(12):2087-9. PubMed ID: 24863690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.